Fluvoxamine in the treatment of anxiety disorders

Fluvoxamine is a selective-serotonin reuptake inhibitor (SSRI) that has proved effective in large double-blind, randomized, controlled trials involving patients with social anxiety disorder (SAD), obsessive-compulsive disorder (OCD), and panic disorder. Improvements have also been demonstrated in pa...

Descripción completa

Detalles Bibliográficos
Autor principal: Irons, Jane
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2005
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2424117/
https://www.ncbi.nlm.nih.gov/pubmed/18568110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2424117/
https://www.ncbi.nlm.nih.gov/pubmed/18568110

Ejemplares similares